DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Biologic Drugs cited in Barkan Wireless IP Holdings, L.P. v. Samsung Electronics Co., Ltd.
|Date Filed||Document No.||Description||Snippet||Link To Document|
|2018-12-05||71||Claim Construction Brief||contents or delete the information therein.” Id. at 10:41– 44. Defendants contend base station hardware…one form of claimed tamper-proofing. See id. at 10:41–44 (“This black box can be tamper-free, including…tampering” with billing and pricing policies); id. at 10:41–44 (describing tamper-proofing to include “delet[…A U.S. Patent No. 8,014,284 Exhibit B U.S. Patent No. 8,559,312 Exhibit C U.S. Patent No. 9,392,638… ’638 patent, and refers 8 The Patents-in-Suit claim priority based on a Patent Cooperation||External link to document|
|2018-12-21||80||information therein as discussed at 10:41-44 of the ’312 patent. Indeed, the statement that the “black…terms of U.S. Patent Nos. 8,014,284 (the “’284 patent”), 8,559,312 (the “’312 patent) and 9,392,638 …9,392,638 (the “’638 patent”) (collectively, the “Asserted Patents” or “Patents-in-Suit”). Specifically, I have…of the claims as well as the entire patent, including the patent specification and figures. I also understand…than the term “gateway” used in the ’284 patent and ’312 patent claims is used to avoid||External link to document|
|>Date Filed||>Document No.||>Description||>Snippet||>Link To Document|